Skip to main content
AmigoFish

Ep 76-Nonconsensual Studies: Dr. Halikas and Marginalization of a Hmong Community

From Doctoring the Truth · · 1 hr 10 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

Send us Fan Mail (https://www.buzzsprout.com/2417487/fan_mail/new)

A patient walks into a hospital for help with opioid withdrawal, accepts a medication offered by a doctor, and later learns that dose was part of an experiment. That single shift, from treatment to research, is where trust can break for good.

This story forces a bigger conversation about clinical research ethics, vulnerable populations, interpreters, and the power dynamics inside detox units. We explore how the sponsor-investigator role concentrates responsibility, how an IRB (institutional review board) is supposed to function as a barrier between scientific ambition and human rights, and why teach-back and community-engaged research are now seen as essential safeguards rather than optional extras. Trigger warning: substance use disorder, opioid withdrawal, medical experimentation, informed consent failures, and exploitation of vulnerable patients.

If you care about informed consent, FDA oversight, and what patients are owed when medicine turns into research, listen now, then share this episode and leave a review so more people can find the show.

Resources:

U.S. Food and Drug Administration

Commissioner’s final decision disqualifying James A. Halikas, M.D., from receiving investigational drugs, January 17, 2001.

U.S. Food and Drug Administration

Presiding officer’s detailed summary decision addressing the informed-consent violations, Halikas’s defenses, and the unresolved allegations involving language, coercion, and dosing.

Halikas v. University of Minnesota, 856 F. Supp. 1331 (D. Minn. 1994)

Federal court decision describing the GHB Opium Study, the University’s Institutional Review Board investigation, Halikas’s due-process arguments, and the court’s refusal to prevent dissemination of the investigation’s findings.

FDA Clinical Investigator Disqualification Proceedings Database

Public listing showing James A. Halikas as disqualified effective January 17, 2001.

University of Minnesota Clinical and Translational Science Institute

Information about SoLaHmo and community-driven research involving Somali, Latino, and Hmong communities.

Support the show (https://www.buzzsprout.com/2417487/support)

Don't miss a (heart) beat! Check out our Instagram @doctoringthetruthpodcast and email us your Medical Mishaps at doctoringthetruth@gmail.com.

Check out these fantastic discounts using promo code STAYSUSPICIOUS from our sponsors at:

*https://strongcoffeecompany.com/discount/STAYSUSPICIOUS for 20% off

*www.handful.com (http://www.handful.com) for 30% off

*www.standshoes.com (http://www.standshoes.com) for 15% off

*www.getcheeky.com (http://getcheeky.com) for 30% off

*https://mollybz.com for 10% off

*klearprotein.com (http://klearprotein.com) for 20% off

*www.torrain.org for 15% off

*www.cozyearth.com for 21% off

* www.yarokhair.com (http://www.yarokhair.com) for 15% off

*www.loveindus.com for 21% off

https://www.tumbleweedandoak.com for 15% off

www.aspiredrinks.com 20% OFF

www.tonaactive.com (http://www.tonaactive.com) for 16% off

distilunion.com (http://distiluntion.com) for 20% off

...

Back to Doctoring the Truth · Report a problem